nach oben

Erschienen in:

13.03.2020 | Original Article

Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression

verfasst von: Xiaoning Zhang, Zhiqiang Zhang, Mingyan Ju, Jiaci Li, Yaqing Jing, Yuxia Zhao, Chao Gu, Ming Dong, Guang Li, Yi Liu

Erschienen in: Inflammopharmacology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Acute lung injury (ALI)-triggered pulmonary injury has been associated with high mortality, despite advances in drug treatment and supportive therapy. Remarkable progress has been made in attenuating the inflammatory injury associated with ALI using mesenchymal stem cells (MSCs)-based cell and gene therapy. However, to date, the benefits of interleukin-35 (IL-35)-modified MSCs in ALI intervention have not been investigated. In the present study, adult male C57BL/6 mice randomly received intravenous infusion of adipose-derived mesenchymal stem cells (ADSCs) constitutively expressing IL-35 (IL-35-GFP-ADSCs) or GFP (GFP-ADSCs) via retrovirus-mediated transduction (8 × 10⁵ cells per mice) or isotonic saline 7 days before ALI modeling to investigate the effect and related mechanism. ALI was performed by lipopolysaccharide (LPS) inhalation for 24 h. Normal mice served as the sham group. The results indicated that compared with GFP-ADSCs, IL-35-modified ADSCs significantly increased cellular and pulmonary IL-10 and IL-35 production. Pretreatment with IL-35-ADSCs markedly reduced body weight loss, pulmonary wet/dry weight ratio and pathological injury. The PO₂ was rescued to normal levels in mice that received IL-35-ADSCs. IL-35-ADSCs infusion apparently inhibited IL-6 release, protein leakage and MPO activity but greatly elevated IL-35 level in the bronchoalveolar lavage fluid (BALF). Splenic regulatory T cells in IL-35-ADSCs-pretreated mice got effective increase. Moreover, IL-35-ADSCs pretreatment remarkably inhibited neutrophil and macrophage infiltration and greatly decreased IL-6, tumor necrosis factor α (TNF-α) and Toll-like receptor 4 (TLR4) expression. In conclusion, pretreatment with IL-35-engineered ADSCs provided effective protection against LPS-induced ALI through suppression of pulmonary inflammation and, thus, might be a promising strategy to improve outcomes after ALI. The enhanced paracrine and immunosuppressive capacity of IL-35-ADSCs might contribute to their beneficial effects. However, further studies are needed to illuminate the detailed mechanism.

Bellani G et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA J Am Med Assoc 315:788–800. https://doi.org/10.1001/jama.2016.0291CrossRef

Castellani ML et al (2010) IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg cells. J Biol Regul Homeost Agents 24:131–135PubMed

Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA (2013) Retraction. Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 191:2018. https://doi.org/10.4049/jimmunol.1390040CrossRefPubMedPubMedCentral

Chen XX, Zhang YL, Wang WJ, Liu ZQ, Meng JG, Han ZH (2018) Mesenchymal stem cells modified with heme oxygenase-1 have enhanced paracrine function and attenuate lipopolysaccharide-induced inflammatory and oxidative damage in pulmonary microvascular endothelial cells. Cell Physiol Biochem 49:101–122. https://doi.org/10.1159/000492847CrossRefPubMed

Chen X et al (2019) Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats. J Cell Physiol 234:7301–7319. https://doi.org/10.1002/jcp.27488CrossRefPubMed

Cho YJ et al (2016) Clinical practice guideline of acute respiratory distress syndrome. Tuberc Respir Dis 79:214–233. https://doi.org/10.4046/trd.2016.79.4.214CrossRef

Cobbold SP et al (2003) Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 196:109–124CrossRef

Collison LW et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566–569. https://doi.org/10.1038/nature06306CrossRefPubMed

Collison LW et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093–1101. https://doi.org/10.1038/ni.1952CrossRefPubMedPubMedCentral

D'Alessio FR et al (2009) CD4(+)CD25(+)Foxp3(+) Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Investig 119:2898–2913. https://doi.org/10.1172/JCI36498CrossRefPubMed

Fanelli V, Ranieri VM (2015) Mechanisms and clinical consequences of acute lung injury. Ann Am Thorac Soc 12(Suppl 1):S3–8. https://doi.org/10.1513/AnnalsATS.201407-340MGCrossRefPubMed

Grommes J, Soehnlein O (2011) Contribution of neutrophils to acute lung injury. Mol Med 17:293–307. https://doi.org/10.2119/molmed.2010.00138CrossRefPubMed

Guo H, Zhao N, Gao H, He X (2017) Mesenchymal stem cells overexpressing interleukin-35 propagate immunosuppressive effects in mice. Scand J Immunol 86:389–395. https://doi.org/10.1111/sji.12613CrossRefPubMed

Henderson RB, Hobbs JAR, Mathies M, Hogg N (2003) Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102:328–335. https://doi.org/10.1182/blood-2002-10-3228CrossRefPubMed

Kuo J, Nardelli DT, Warner TF, Callister SM, Schell RF (2011) Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol 18:1125–1132. https://doi.org/10.1128/CVI.00052-11CrossRefPubMedPubMedCentral

Li DQ et al (2016) Bone marrow mesenchymal stem cells suppress acute lung injury induced by lipopolysaccharide through inhibiting the Tlr 2, 4/Nf-kappa B pathway in rats with multiple trauma. Shock 45:641–646. https://doi.org/10.1097/Shk.0000000000000548CrossRefPubMed

Lin SH, Wu H, Wang CJ, Xiao ZB, Xu F (2018) Regulatory T cells and acute lung injury: cytokines, uncontrolled inflammation, and therapeutic implications. Front Immunol. https://doi.org/10.3389/Fimmu.2018.01545CrossRefPubMedPubMedCentral

Maddaloni M, Kochetkova I, Hoffman C, Pascual DW (2018) Delivery of IL-35 by Lactococcus lactis ameliorates collagen-induced arthritis in mice. Front Immunol. https://doi.org/10.3389/Fimmu.2018.02691CrossRefPubMedPubMedCentral

Manabe T et al (2018) Clinical outcomesin patients with acute respiratory distress syndrome (Ards) in Vietnam according to severity of the Berlin definition. Respirology 23:262–262

Marriott HM, Dockrell DH (2007) The role of the macrophage in lung disease mediated by bacteria. Exp Lung Res 33:493–505. https://doi.org/10.1080/01902140701756562CrossRefPubMed

Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Investig 122:2731–2740. https://doi.org/10.1172/JCI60331CrossRefPubMed

Monge RH et al (2014) Incidence, outcomes and risk factors associated with the development of acute lung injury and at respiratory distress syndrome in patients with severe sepsis and septic shock admitted to ICU. Results of a Spanish Multicenter Study. Intens Care Med 40:S133–S133CrossRef

Ozdemir RBO, Ozdemir AT, Sariboyaci AE, Uysal O, Tuglu MI, Kirmaz C (2019) The investigation of immunomodulatory effects of adipose tissue mesenchymal stem cell educated macrophages on the CD4 T cells. Immunobiology 224:585–594. https://doi.org/10.1016/j.imbio.2019.04.002CrossRefPubMedPubMedCentral

Shi Y et al (2010) Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 20:510–518. https://doi.org/10.1038/cr.2010.44CrossRefPubMed

Soliman MG, Mansour HA, Hassan WA, El-Sayed RA, Hassaan NA (2018) Mesenchymal stem cells therapeutic potential alleviate lipopolysaccharide-induced acute lung injury in rat model. J Biochem Mol Toxic. https://doi.org/10.1002/jbt.22217CrossRef

Tian WJ et al (2015) Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice. Lung 193:85–95. https://doi.org/10.1007/s00408-014-9654-xCrossRefPubMed

Wang JC, Qin Y, Mi XJ (2016) The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-kappa B signaling pathways. Biomed Pharmacother 79:176–187. https://doi.org/10.1016/j.biopha.2016.02.037CrossRefPubMed

Wang CF, Lv D, Zhang XB, Ni ZA, Sun XF, Zhu CQ (2018a) Interleukin-10-overexpressing mesenchymal stromal cells induce a series of regulatory effects in the inflammatory system and promote the survival of endotoxin-induced acute lung injury in mice model. DNA Cell Biol 37:53–61. https://doi.org/10.1089/dna.2017.3735CrossRefPubMed

Wang L et al (2018b) Recovery from acute lung injury can be regulated via modulation of regulatory T cells and Th17 cells. Scand J Immunol 88:e12715. https://doi.org/10.1111/sji.12715CrossRefPubMed

Wang Y et al (2018c) IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells. J Cell Mol Med 22:1014–1025. https://doi.org/10.1111/jcmm.13428CrossRefPubMed

Wang CJ, Zhang M, Wu H, Lin SH, Xu F (2019) IL-35 interferes with splenic T cells in a clinical and experimental model of acute respiratory distress syndrome. Int Immunopharmacol 67:386–395. https://doi.org/10.1016/j.intimp.2018.12.024CrossRefPubMed

Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349. https://doi.org/10.1056/NEJM200005043421806CrossRefPubMed

Wilhelmsen K, Mesa KR, Prakash A, Xu F, Hellman J (2012) Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response. Innate Immun 18:602–616. https://doi.org/10.1177/1753425911429336CrossRefPubMed

Williams AE, Chambers RC (2014) The mercurial nature of neutrophils: still an enigma in ARDS? Am J Physiol Lung Cell Mol Physiol 306:L217–230. https://doi.org/10.1152/ajplung.00311.2013CrossRefPubMed

Yao XP et al (2015) Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Biomaterials 60:130–140. https://doi.org/10.1016/j.biomaterials.2015.04.046CrossRefPubMed

Zhang F, Li MY, Lan YT, Wang CB (2016) Imbalance of Th17/Tregs in rats with smoke inhalation-induced acute lung injur. Sci Rep 6:21348. https://doi.org/10.1038/srep21348CrossRefPubMedPubMedCentral

Zhang B et al (2018a) Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice. J Transl Med 16:71. https://doi.org/10.1186/s12967-018-1441-7CrossRefPubMedPubMedCentral

Zhang SQ, Jiang W, Ma LJ, Liu YH, Zhang XY, Wang S (2018b) Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide. J Cell Biochem 119:1627–1636. https://doi.org/10.1002/jcb.26322CrossRefPubMed

Zhang XN et al (2018c) Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice. PeerJ. https://doi.org/10.7717/Peerj.5638CrossRefPubMedPubMedCentral

Titel: Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression
verfasst von: Xiaoning Zhang
Zhiqiang Zhang
Mingyan Ju
Jiaci Li
Yaqing Jing
Yuxia Zhao
Chao Gu
Ming Dong
Guang Li
Yi Liu
Publikationsdatum: 13.03.2020
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 5/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-020-00696-5

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Conditional nutrition (I): concerning zinc as a beneficial but variable regulator of inflammation and experimental arthritis

A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties

Apixaban exhibits anti-arthritic effects by inhibiting activated factor X-mediated JAK2/STAT3 and MAPK phosphorylation pathways

Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways